USA TODAY |
Mylan to pay $465M settlement over EpiPen pricing, cuts earnings guidance
USA TODAY Mylan, the embattled maker of allergy treatment EpiPen, lowered its 2016 earnings guidance Friday after it agreed to pay $465 million in a settlement with federal regulators over pricing practices. “The terms of the settlement do not provide for any … Mylan Surges After Quickly Settling With DoJ Over EpiPen Medicaid RebatesForbes Mylan pays $465 million to settle EpiPen Medicaid rebate disputeReuters Mylan in $465 million settlement over EpiPen classification; trims forecastCNBC Washington Post –New York Times –NBCNews.com –Wall Street Journal all 56 news articles » |
Source: Weather